NervGen Pharma Corp.: NervGen Pharma Establishes Alzheimer s Disease Scientific Advisory Board
Vancouver, British Columbia (Newsfile Corp. - January 26, 2021) -
NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ( NervGen or the Company ), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today announced the formation of its Alzheimer s Disease Scientific Advisory Board ( AD-SAB ) with the appointment of four world-class scientists and clinical researchers in Alzheimer s disease: Jeffrey Cummings, MD, ScD; George Perry, PhD; Henrik Zetterberg, MD, PhD; and Bruce Lamb, PhD. The AD-SAB will work closely with NervGen as the Company plans its upcoming preclinical studies and clinical trials and in the analyses of the results from these studies.
Image: DPA via Getty Images (ABC News) –Siegfried Fischbacher, the surviving member of famed entertainment duo Siegfried and Roy, died in Las Vegas from pancreatic cancer, a rep for the legendary illusionist confirmed to ABC News. Fischbacher was 81. His sister, a nun who lives in Munich, told the German news agency dpa that she was able to talk to.
The UFC has been in contact with Johns Hopkins University about its psychedelics studies with an eye toward seeing if the drugs can be helpful for fighters dealing with brain issues.
The UFC has been in contact with Johns Hopkins University about its psychedelics studies with an eye toward seeing if the drugs can be helpful for fighters dealing with brain issues.